Author

E. Flannery

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:plant (other)· 1

Frequent Co-Authors

A. G. Jamieson· 1 shared A. Jex· 1 shared A. Lerch· 1 shared A. Mahindra· 1 shared A. P. Waters· 1 shared A. Sanchez-Azqueta· 1 shared A. Tobin· 1 shared B. Ansell· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. G. Jamieson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and potential mechanisms for liver-stage differentiation.

A. Jex, I. Mueller, S. Kappe, S. Mikolajcjak, J. Sattabongkot, R. Patrapuvich, S. Lindner, E. Flannery, C. Koepfli, B. Ansell, A. Lerch, K. E. Swearingen, S. J. Emery-Corbin, S. Charnaud, J. Smith, , V. Chuenchob

This study characterizes the transcriptome and histone epigenome of Plasmodium vivax sporozoites, revealing transcriptional and post-transcriptional control mechanisms and potential pathways for hypnozoite formation.

bioRxiv · Dec 3, 2018 · PreprintMicrobiology

Validation of the protein kinase PfCLK3 as a multi-stage cross species malarial drug target

M. Alam, A. Sanchez-Azqueta, O. Janha, E. Flannery, A. Mahindra, K. Mapesa, N. Brancucci, Y. Antonova-Koch, K. Crouch, N. V. Simwela, J. Akinwale, D. Mitcheson, L. Solyakov, K. Dudek, C. Jones, , A. Tobin

This study identifies PfCLK3 as a druggable target for malaria by showing its essential role in multiple parasite life stages across species.

bioRxiv · Aug 31, 2018 · PreprintMicrobiology